ICU Medical, Inc. ICUI
182.11 USD +3.26 (+1.82%)
At closeNov 10, 2026, 4:00 PM EST
182.11 0.00 0.00%
After hours · Nov 10, 4:00 PM ET
176.86 Day range 183.03
113.37 52-week range 192.85
- YTD
- +27.64%
- 1 year
- +30.80%
News
benzinga.com Keybanc Maintains Overweight on ICU Medical, Raises Price Target to $189 Keybanc analyst Brett Fishbin maintains ICU Medical (NASDAQ:ICUI) with a Overweight and raises the price target from $187 to $189.
benzinga.com Piper Sandler Maintains Overweight on ICU Medical, Raises Price Target to $200 Piper Sandler analyst Jason Bednar maintains ICU Medical (NASDAQ:ICUI) with a Overweight and raises the price target from $195 to $200.
benzinga.com ICU Medical Q3 2026 Earnings Call Transcript ICU Medical (NASDAQ:ICUI) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you…- benzinga.com ICU Medical Affirms FY2026 GAAP EPS Guidance of $2.89-$3.29 vs $3.47 Est ICU Medical (NASDAQ:ICUI) affirms FY2026 GAAP EPS guidance from $2.89-$3.29 to $2.89-$3.29 vs $3.47 analyst estimate..
benzinga.com ICU Medical Affirms FY2026 Adj EPS Guidance of $8.60-$9.00 vs $8.74 Est ICU Medical (NASDAQ:ICUI) affirms FY2026 Adj EPS guidance from $8.60-$9.00 to $8.60-$9.00 vs $8.74 analyst estimate..
benzinga.com ICU Medical Q3 Adj. EPS $2.44 Beats $2.14 Estimate, Sales $560.439M Beat $552.071M Estimate ICU Medical (NASDAQ:ICUI) reported quarterly earnings of $2.44 per share which beat the analyst consensus estimate of $2.14 by 14.02 percent. This is a 20.2 percent increase over earnings of $2.03…
benzinga.com Piper Sandler Maintains Overweight on ICU Medical, Raises Price Target to $195 Piper Sandler analyst Jason Bednar maintains ICU Medical (NASDAQ:ICUI) with a Overweight and raises the price target from $163 to $195.
benzinga.com ICU Medical Analysts Boost Their Forecasts Following Upbeat Q2 Earnings ICU Medical Inc (NASDAQ:ICUI) reported strong Q2 earnings of $2.37 per share and raised its FY2026 guidance. Analysts have increased price targets for the stock.
benzinga.com BTIG Maintains Buy on ICU Medical, Raises Price Target to $200 BTIG analyst Sam Eiber maintains ICU Medical (NASDAQ:ICUI) with a Buy and raises the price target from $170 to $200.
benzinga.com Needham Maintains Buy on ICU Medical, Raises Price Target to $187 Needham analyst Mike Matson maintains ICU Medical (NASDAQ:ICUI) with a Buy and raises the price target from $165 to $187.- benzinga.com ICU Medical Raises FY2026 Adj EPS Guidance from $7.75-$8.45 to $8.60-$9.00 vs $8.16 Est ICU Medical (NASDAQ:ICUI) raises FY2026 Adj EPS guidance from $7.75-$8.45 to $8.60-$9.00 vs $8.16 analyst estimate..
- benzinga.com ICU Medical Raises FY2026 GAAP EPS Guidance from $1.03-$1.74 to $2.89-$3.29 vs $2.77 Est ICU Medical (NASDAQ:ICUI) raises FY2026 GAAP EPS guidance from $1.03-$1.74 to $2.89-$3.29 vs $2.77 analyst estimate..
benzinga.com ICU Medical Q2 Adj. EPS $2.37 Beats $1.91 Estimate, Sales $551.700M Beat $533.428M Estimate ICU Medical (NASDAQ:ICUI) reported quarterly earnings of $2.37 per share which beat the analyst consensus estimate of $1.91 by 24.08 percent. This is a 12.86 percent increase over earnings of $2.10…
benzinga.com Keybanc Maintains Overweight on ICU Medical, Raises Price Target to $182 Keybanc analyst Brett Fishbin maintains ICU Medical (NASDAQ:ICUI) with a Overweight and raises the price target from $164 to $182.
benzinga.com This ICU Medical Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday Top Wall Street analysts changed outlook on top names. Find all rating changes on Benzinga's analyst ratings page. See analyst views on ICUI, BDSX,.
benzinga.com BTIG Initiates Coverage On ICU Medical with Buy Rating, Announces Price Target of $170 BTIG analyst Sam Eiber initiates coverage on ICU Medical (NASDAQ:ICUI) with a Buy rating and announces Price Target of $170.- benzinga.com UPDATE: FDA Says Aware That ICU Medical Has Issued Customer Communication Recommending Certain Iv Tubing Sets Be Removed From Where They Are Used Or Sold; ICU Medical & FDA Still Assessing Scope Of Potentially High-Risk IV Tubing Sets Issue To Identify Some Models, Lots/UDIs That May Be Affected; As Of May 15, ICU Medical Has Not Reported Any Serious Injuries/deaths Associated With Issue Related To Certain Iv Tubing Sets https://www.fda.gov/medical-devices/medical-device-recalls-and-early-alerts/early-alert-iv-tubing-set-issue-icu-medical
benzinga.com This Gulfport Energy Analyst Turns Bullish; Here Are Top 4 Upgrades For Wednesday Top Wall Street analysts upgraded ICUI, PSX, PARR, and GPOR and raised price targets. Check out analyst ratings for other stocks and their views.- benzinga.com ICU Medical Affirms FY2026 GAAP EPS Guidance of $1.03-$1.74 vs $1.73 Est ICU Medical (NASDAQ:ICUI) affirms FY2026 GAAP EPS guidance from $1.03-$1.74 to $1.03-$1.74 vs $1.73 analyst estimate..
- benzinga.com ICU Medical Affirms FY2026 Adj EPS Guidance of $7.75-$8.45 vs $8.09 Est ICU Medical (NASDAQ:ICUI) affirms FY2026 Adj EPS guidance from $7.75-$8.45 to $7.75-$8.45 vs $8.09 analyst estimate..
- benzinga.com ICU Medical Q1 Adj. EPS $1.97 Beats $1.75 Estimate, Sales $530.200M Beat $520.483M Estimate ICU Medical (NASDAQ:ICUI) reported quarterly earnings of $1.97 per share which beat the analyst consensus estimate of $1.75 by 12.57 percent. This is a 14.53 percent increase over earnings of $1.72…
- benzinga.com Keybanc Maintains Overweight on ICU Medical, Lowers Price Target to $164 Keybanc analyst Brett Fishbin maintains ICU Medical (NASDAQ:ICUI) with a Overweight and lowers the price target from $180 to $164.
- benzinga.com Piper Sandler Maintains Overweight on ICU Medical, Lowers Price Target to $163 Piper Sandler analyst Jason Bednar maintains ICU Medical (NASDAQ:ICUI) with a Overweight and lowers the price target from $178 to $163.
benzinga.com EXCLUSIVE: Petrochemical Crunch From Iran War Isn't Hitting Hospitals Yet—But Analysts Say Costs For Critical Medical Supplies Could Rise Within Weeks Oil prices have risen. Here's how Strait of Hormuz tensions could soon increase healthcare costs and make everyday medical supplies more expensive.- benzinga.com Keybanc Maintains Overweight on ICU Medical, Raises Price Target to $180 Keybanc analyst Brett Fishbin maintains ICU Medical (NASDAQ:ICUI) with a Overweight and raises the price target from $175 to $180.
- benzinga.com Piper Sandler Maintains Overweight on ICU Medical, Raises Price Target to $178 Piper Sandler analyst Jason Bednar maintains ICU Medical (NASDAQ:ICUI) with a Overweight and raises the price target from $172 to $178.
benzinga.com Insights into ICU Medical Q4 Earnings - benzinga.com ICU Medical Q4 Adj. EPS $1.91 Beats $1.69 Estimate, Sales $540.704M Beat $530.633M Estimate ICU Medical (NASDAQ:ICUI) reported quarterly earnings of $1.91 per share which beat the analyst consensus estimate of $1.69 by 12.88 percent. This is a 9.48 percent decrease over earnings of $2.11…
benzinga.com Earnings Scheduled For February 19, 2026 
benzinga.com Earnings Preview For ICU Medical - benzinga.com US FDA Says ICU Medical Recalling IV Gravity Burette Set Due To Burette Component Missing Internal Shut-Off Valve Intended To Stop Fluid Flow https://www.fda.gov/medical-devices/medical-device-recalls-and-early-alerts/intravascular-administration-set-recall-icu-medical-removes-iv-gravity-burette-set
- benzinga.com Keybanc Maintains Overweight on ICU Medical, Raises Price Target to $175 Keybanc analyst Brett Fishbin maintains ICU Medical (NASDAQ:ICUI) with a Overweight and raises the price target from $173 to $175.
- benzinga.com Piper Sandler Maintains Overweight on ICU Medical, Raises Price Target to $172 Piper Sandler analyst Jason Bednar maintains ICU Medical (NASDAQ:ICUI) with a Overweight and raises the price target from $153 to $172.
- benzinga.com ICU Medical Raises FY2025 Adj EPS Guidance from $6.85-$7.15 to $7.35-$7.65 vs $6.99 Est ICU Medical (NASDAQ:ICUI) raises FY2025 Adj EPS guidance from $6.85-$7.15 to $7.35-$7.65 vs $6.99 analyst estimate..
- benzinga.com ICU Medical Q3 Adj. EPS $2.03 Beats $1.43 Estimate, Sales $536.990M Beat $510.440M Estimate ICU Medical (NASDAQ:ICUI) reported quarterly earnings of $2.03 per share which beat the analyst consensus estimate of $1.43 by 41.66 percent. This is a 27.67 percent increase over earnings of $1.59…
benzinga.com Earnings Scheduled For November 6, 2025 - benzinga.com What Analysts Are Saying About ICU Medical Stock
- benzinga.com Keybanc Maintains Overweight on ICU Medical, Lowers Price Target to $173 Keybanc analyst Brett Fishbin maintains ICU Medical (NASDAQ:ICUI) with a Overweight and lowers the price target from $191 to $173.
- benzinga.com Piper Sandler Maintains Overweight on ICU Medical, Raises Price Target to $153 Piper Sandler analyst Jason Bednar maintains ICU Medical (NASDAQ:ICUI) with a Overweight and raises the price target from $145 to $153.
benzinga.com This Parker-Hannifin Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - benzinga.com Piper Sandler Initiates Coverage On ICU Medical with Overweight Rating, Announces Price Target of $145 Piper Sandler analyst Jason Bednar initiates coverage on ICU Medical (NASDAQ:ICUI) with a Overweight rating and announces Price Target of $145.
- benzinga.com Raymond James Maintains Strong Buy on ICU Medical, Lowers Price Target to $180 Raymond James analyst Jayson Bedford maintains ICU Medical (NASDAQ:ICUI) with a Strong Buy and lowers the price target from $187 to $180.
- benzinga.com ICU Medical Narrows FY2025 Adj EPS Guidance from $6.55-$7.25 to $6.85-$7.15 vs $6.64 Est ICU Medical (NASDAQ:ICUI) narrows FY2025 Adj EPS guidance from $6.55-$7.25 to $6.85-$7.15 vs $6.64 analyst estimate..
- benzinga.com ICU Medical Q2 Adj. EPS $2.10 Beats $1.50 Estimate, Sales $548.866M Beat $542.500M Estimate ICU Medical (NASDAQ:ICUI) reported quarterly earnings of $2.10 per share which beat the analyst consensus estimate of $1.50 by 40 percent. This is a 34.62 percent increase over earnings of $1.56 per…
- benzinga.com Earnings Scheduled For August 7, 2025
- benzinga.com Earnings Scheduled For May 8, 2025
- benzinga.com Earnings Scheduled For February 27, 2025
- benzinga.com Earnings Scheduled For November 12, 2024
- benzinga.com Spectrum Brands Posts Upbeat Results, Joins AerSale, Sinclair, ICU Medical And Other Big Stocks Moving Higher On Thursday
- benzinga.com Earnings Scheduled For February 27, 2024 Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on revenue of $100.49 million.